BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26482476)

  • 1. Treatment of brain oligometastases with hypofractionated stereotactic radiotherapy utilising volumetric modulated arc therapy.
    Croker J; Chua B; Bernard A; Allon M; Foote M
    Clin Exp Metastasis; 2016 Feb; 33(2):125-32. PubMed ID: 26482476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
    Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
    Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HFSRT of the resection cavity in patients with brain metastases.
    Specht HM; Kessel KA; Oechsner M; Meyer B; Zimmer C; Combs SE
    Strahlenther Onkol; 2016 Jun; 192(6):368-76. PubMed ID: 26964777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated stereotactic radiotherapy for brain metastases: a dosimetric and treatment efficiency comparison between volumetric modulated arc therapy and intensity modulated radiotherapy.
    Ma Y; Li M; Yin Y; Kong L; Sun X; Lin X; Yu J
    Technol Cancer Res Treat; 2010 Oct; 9(5):499-507. PubMed ID: 20815421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluatıon of hypofractıonated stereotactıc radıotherapy (HFSRT) to the resectıon cavıty after surgıcal resectıon of braın metastases: A sıngle center experıence.
    Dincoglan F; Sager O; Uysal B; Demiral S; Gamsiz H; Gündem E; Elcim Y; Dirican B; Beyzadeoglu M
    Indian J Cancer; 2019; 56(3):202-206. PubMed ID: 31389381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metastases treated with radiosurgery or hypofractionated stereotactic radiotherapy: outcomes and predictors of survival.
    Sallabanda M; García-Berrocal MI; Romero J; García-Jarabo V; Expósito MJ; Rincón DF; Zapata I; Magallón MR
    Clin Transl Oncol; 2020 Oct; 22(10):1809-1817. PubMed ID: 32124243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M; Pin Y; Thierry A; Clavier JB
    Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
    Keller A; Doré M; Cebula H; Thillays F; Proust F; Darié I; Martin SA; Delpon G; Lefebvre F; Noël G; Antoni D
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1179-1189. PubMed ID: 28974415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volumetric Intensity-Modulated Arc Stereotactic Radiosurgery Boost in Oligometastatic Patients with Spine Metastases: a Dose-escalation Study.
    Deodato F; Pezzulla D; Cilla S; Ferro M; Giannini R; Romano C; Boccardi M; Buwenge M; Valentini V; Morganti AG; Macchia G
    Clin Oncol (R Coll Radiol); 2023 Jan; 35(1):e30-e39. PubMed ID: 36207236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases.
    Narayana A; Chang J; Yenice K; Chan K; Lymberis S; Brennan C; Gutin PH
    Stereotact Funct Neurosurg; 2007; 85(2-3):82-7. PubMed ID: 17167236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection.
    Bilger A; Bretzinger E; Fennell J; Nieder C; Lorenz H; Oehlke O; Grosu AL; Specht HM; Combs SE
    Cancer Med; 2018 Jun; 7(6):2350-2359. PubMed ID: 29745035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results.
    Macchia G; Deodato F; Cilla S; Torre G; Corrado G; Legge F; Gambacorta MA; Tagliaferri L; Mignogna S; Scambia G; Valentini V; Morganti AG; Ferrandina G
    Oncol Rep; 2014 Nov; 32(5):2237-43. PubMed ID: 25175950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionated stereotactic radiotherapy for large brain metastases: Optimizing the dosimetric parameters.
    Brun L; Dupic G; Chassin V; Chautard E; Moreau J; Dedieu V; Khalil T; Verrelle P; Lapeyre M; Biau J
    Cancer Radiother; 2021 Feb; 25(1):1-7. PubMed ID: 33257109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation.
    Mengue L; Bertaut A; Ngo Mbus L; Doré M; Ayadi M; Clément-Colmou K; Claude L; Carrie C; Laude C; Tanguy R; Blanc J; Sunyach MP
    Radiat Oncol; 2020 Apr; 15(1):82. PubMed ID: 32303236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.
    Fiorentino A; Giaj-Levra N; Tebano U; Mazzola R; Ricchetti F; Fersino S; Di Paola G; Aiello D; Ruggieri R; Alongi F
    Radiol Med; 2017 Sep; 122(9):676-682. PubMed ID: 28447313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain metastases: Single-dose radiosurgery versus hypofractionated stereotactic radiotherapy: A retrospective study.
    de la Pinta C; Fernández-Lizarbe E; Sevillano D; Capúz AB; Martín M; Hernanz R; Vallejo C; Martín M; Sancho S
    J Clin Transl Res; 2020 Jul; 6(1):6-13. PubMed ID: 32875136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.